Intrathecal Chemotherapy Through Ommaya Reservoir in Leptomeningeal Metastasis From Cervical Cancer: A Rare Case Report and Literature Review.

J Obstet Gynaecol ResSep 1, 2026
Case ReportOncology (Medical)NeurologyOpen access

Chery Ahn, Haein Seo, Dongmin Jo et al.

✦ AI-curated · Sources linked

Case in brief

A 61-year-old woman with stage IVB cervical squamous cell carcinoma presented with acute headache and diplopia during systemic chemotherapy. Brain MRI indicated leptomeningeal metastasis, confirmed by CSF cytology. An Ommaya reservoir was placed for intrathecal methotrexate therapy, leading to rapid neurological improvement and sustained clearance of malignant cells. Despite systemic disease progression, LM-related symptoms were well managed, and the patient survived for 8 months post-diagnosis.

Diagnostic / clinical pearl

Clinicians should consider leptomeningeal metastasis in cervical cancer patients presenting with new neurological symptoms, as timely intervention can lead to significant symptomatic relief.

Why it matters

This case underscores the potential effectiveness of intrathecal chemotherapy via an Ommaya reservoir in managing neurological symptoms associated with leptomeningeal metastasis.

Source

Published in J Obstet Gynaecol Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.